A Clinical Trial to evaluate the Malbet Product for Malaria.
Phase 3
- Conditions
- Health Condition 1: null- Malaria
- Registration Number
- CTRI/2012/08/002913
- Lead Sponsor
- Solar Herbo Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
1.Age above 18 years.
2.Both the sex.
3.Patients suffering with malaria.
4.Patients willing to sign informed consent.
Exclusion Criteria
1.Patients below 18 years of age.
2.Pregnant Women.
3.Patient not willing to sign informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical recovery from the current symptoms of malaria.Timepoint: 5 Days
- Secondary Outcome Measures
Name Time Method To determine the safety profile of Malbet Capsules in malaria sufferers.Timepoint: 5 Days